Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is GBX 2,283.33.
A number of brokerages have issued reports on JMAT. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 target price on shares of Johnson Matthey in a report on Monday, July 6th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,330 price target on shares of Johnson Matthey in a research note on Tuesday, August 4th.
Read Our Latest Stock Analysis on JMAT
Johnson Matthey Stock Up 1.8%
Insider Activity at Johnson Matthey
In other news, insider Liam Condon bought 10,951 shares of the business’s stock in a transaction on Friday, September 11th. The shares were bought at an average cost of GBX 2,306 per share, for a total transaction of £252,530.06. Also, insider Alastair Judge purchased 12 shares of Johnson Matthey stock in a transaction dated Wednesday, August 12th. The shares were purchased at an average cost of GBX 2,193 per share, for a total transaction of £263.16. Over the last 90 days, insiders bought 28,636 shares of company stock worth $64,995,344. 0.74% of the stock is currently owned by company insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
